Human PTGR2 Inactivation Alters Eicosanoid Metabolism and Cytokine Response of Inflammatory Macrophages
ACS Chemical Biology · 2025-06-20 · 20 (6) · 1426-1434
DOI: 10.1021/acschembio.5c00231 ↗At a glance
Journal article in ACS Chemical Biology, published online on 2025-05-19. Written by Michael W Founds and 6 co-authors. Institution: Department of Chemistry, University of Texas at Austin, Austin, Texas 78712, United States. Major MEDLINE topics: Cytokines, Eicosanoids, Macrophages, Triazoles. Cited 4 times so far (Crossref); 26 references. The full text is freely available in PubMed Central. Funded by: NIAID NIH HHS, NIDA NIH HHS, NIGMS NIH HHS.
Abstract (original language)
Prostaglandin reductase 2 (PTGR2) regulates inflammatory lipid signaling through the metabolism of the PGE2 metabolite 15-keto-PGE2. PTGR2 inhibitors have been reported but whether small molecule inactivation can recapitulate the anti-inflammatory phenotype observed in PTGR2 knockout systems has not been explored. Here, we disclose an optimized sulfonyl triazole (SuTEx) inhibitor of human PTGR2 that blocks biochemical activity by liganding the noncatalytic tyrosines Y100 and Y265 in the active site. Quantitative and multiplexed chemoproteomics verified covalent engagement of endogenous PTGR2 in THP1 macrophages with moderate proteome-wide selectivity. PTGR2 inactivation with the SuTEx inhibitor resulted in suppression of secreted inflammatory lipids and TNF-α in lipopolysaccharide (LPS)-stimulated macrophages. Collectively, our findings identify a potent covalent inhibitor of human PTGR2 that can serve as a tool compound for exploring lipid metabolism and signaling in macrophages.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Chemistry, University of Texas at Austin, Austin, Texas 78712, United States.
- Department of Chemistry, University of Virginia, Charlottesville, Virginia 22904, United States.
ORCID profiles: Ku-Lung Hsu
Funding
- NIAID NIH HHS
- NIDA NIH HHS
- NIGMS NIH HHS
- Welch Foundation
- National Institute of Allergy and Infectious Diseases
- Cancer Prevention and Research Institute of Texas
- University of Texas at Austin
- National Institute on Drug Abuse
Cite
APA
Founds, M. W., Murtagh, O. L., Grams, R. J., Li, Z., Ciancone, A. M., Seal, R. J., & Hsu, K. L. (2025). Human PTGR2 Inactivation Alters Eicosanoid Metabolism and Cytokine Response of Inflammatory Macrophages. ACS Chemical Biology, 20(6), 1426-1434. https://doi.org/10.1021/acschembio.5c00231
Vancouver
Founds MW, Murtagh OL, Grams RJ, Li Z, Ciancone AM, Seal RJ, et al. Human PTGR2 Inactivation Alters Eicosanoid Metabolism and Cytokine Response of Inflammatory Macrophages. ACS Chemical Biology. 2025;20(6):1426-1434. doi:10.1021/acschembio.5c00231
BibTeX
@article{Founds2025,
author = {Founds, Michael W and Murtagh, Olivia L and Grams, R Justin and Li, Zhihong and Ciancone, Anthony M and Seal, Robert J and Hsu, Ku-Lung},
title = {Human PTGR2 Inactivation Alters Eicosanoid Metabolism and Cytokine Response of Inflammatory Macrophages},
journal = {ACS Chemical Biology},
year = {2025},
volume = {20},
number = {6},
pages = {1426--1434},
doi = {10.1021/acschembio.5c00231}
}
EUVIMED